{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:40:25Z","timestamp":1793482825136,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>The purpose of this review is to summarize the recently published evidence concerning vertebral fracture risk in individuals with diabetes mellitus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Vertebral fracture risk is increased in individuals with T2DM. The presence of vertebral fractures in T2DM is associated with increased non-vertebral fracture risk and mortality. TBS could be helpful to estimate vertebral fracture risk in individuals with T2DM. An increased amount of bone marrow fat has been implicated in bone fragility in T2DM. Results from two recent studies show that both teriparatide and denosumab are effective in reducing vertebral fracture risk also in individuals with T2DM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Individuals with T2DM could benefit from systematic screening in the clinic for presence of vertebral fractures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11914-020-00646-8","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T22:34:57Z","timestamp":1610490897000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Type 2 Diabetes Mellitus and Vertebral Fracture Risk"],"prefix":"10.1007","volume":"19","author":[{"given":"Fjorda","family":"Koromani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8310-3448","authenticated-orcid":false,"given":"Samuel","family":"Ghatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carola","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin H. G.","family":"Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rivadeneira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"issue":"5","key":"646_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047\u201353.","journal-title":"Diabetes Care"},{"issue":"10159","key":"646_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James SL, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990&#x2013;2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","journal-title":"Lancet"},{"issue":"12","key":"646_CR3","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726\u201333.","journal-title":"Osteoporos Int"},{"key":"646_CR4","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/S1297-319X(10)70004-X","volume":"77","author":"A Leboime","year":"2010","unstructured":"Leboime A, et al. Osteoporosis and mortality. Joint Bone Spine. 2010;77:S107\u201312.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"646_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):23\u201357.","journal-title":"Osteoporos Int"},{"issue":"1","key":"646_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2337\/dc19-0925","volume":"43","author":"F Koromani","year":"2020","unstructured":"Koromani F, et al. Vertebral fractures in individuals with type 2 diabetes: more than skeletal complications alone. Diabetes Care. 2020;43(1):137\u201344 Meta analysis across 852,705 individuals in 15 studies concluding that individuals with T2DM have increased risk of vertebral fractures.","journal-title":"Diabetes Care"},{"issue":"5","key":"646_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","volume":"14","author":"DM Black","year":"1999","unstructured":"Black DM, et al. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res. 1999;14(5):821\u20138.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"646_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1359\/JBMR.041214","volume":"20","author":"PD Delmas","year":"2005","unstructured":"Delmas PD, et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res. 2005;20(4):557\u201363.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"646_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"Janghorbani M, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166(5):495\u2013505.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"646_CR10","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","volume":"48","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005;48(7):1292\u20139.","journal-title":"Diabetologia"},{"issue":"10","key":"646_CR11","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00125-014-3289-6","volume":"57","author":"N Napoli","year":"2014","unstructured":"Napoli N, et al. Fracture risk in diabetic elderly men: the MrOS study. Diabetologia. 2014;57(10):2057\u201365.","journal-title":"Diabetologia"},{"issue":"9","key":"646_CR12","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1210\/jc.2006-0614","volume":"91","author":"DE Bonds","year":"2006","unstructured":"Bonds DE, et al. Risk of fracture in women with type 2 diabetes: the Women\u2019s Health Initiative Observational Study. J Clin Endocrinol Metab. 2006;91(9):3404\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"646_CR13","first-page":"1619","volume":"36","author":"L Oei","year":"2013","unstructured":"Oei L, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control. The Rotterdam Study. 2013;36(6):1619\u201328.","journal-title":"The Rotterdam Study"},{"issue":"11","key":"646_CR14","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s00198-017-4183-0","volume":"28","author":"P Jia","year":"2017","unstructured":"Jia P, et al. Risk of low-energy fracture in type 2 diabetes patients: a meta-analysis of observational studies. Osteoporos Int. 2017;28(11):3113\u201321.","journal-title":"Osteoporos Int"},{"issue":"2","key":"646_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40520-016-0562-1","volume":"29","author":"J Dytfeld","year":"2017","unstructured":"Dytfeld J, Michalak M. Type 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies. Aging Clin Exp Res. 2017;29(2):301\u20139.","journal-title":"Aging Clin Exp Res"},{"issue":"6","key":"646_CR16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00264-016-3146-y","volume":"40","author":"J Wang","year":"2016","unstructured":"Wang J, et al. Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies. Int Orthop. 2016;40(6):1299\u2013307.","journal-title":"Int Orthop"},{"key":"646_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/TCRM.S131945","volume":"13","author":"A Moayeri","year":"2017","unstructured":"Moayeri A, et al. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:455\u201368.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"646_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jbmr.3287","volume":"33","author":"N Napoli","year":"2018","unstructured":"Napoli N, et al. Vertebral fracture risk in diabetic elderly men: the MrOS study. J Bone Miner Res. 2018;33(1):63\u20139.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"646_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024067","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, et al. Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 2019;9(1):e024067.","journal-title":"BMJ Open"},{"issue":"5","key":"646_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","volume":"27","author":"L Ma","year":"2012","unstructured":"Ma L, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol. 2012;27(5):319\u201332.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"646_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jbmr.556","volume":"27","author":"LM Giangregorio","year":"2012","unstructured":"Giangregorio LM, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2012;27(2):301\u20138 Important study documenting that the fracture risk in individuals with T2DM have an increased risk of fracture that is independent of BMD and underestimated by FRAX.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"646_CR22","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/dc12-1355","volume":"36","author":"VV Zhukouskaya","year":"2013","unstructured":"Zhukouskaya VV, et al. Prevalence of morphometric vertebral fractures in patients with type 1 diabetes. Diabetes Care. 2013;36(6):1635\u201340.","journal-title":"Diabetes Care"},{"issue":"6","key":"646_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11914-017-0410-z","volume":"15","author":"D Hans","year":"2017","unstructured":"Hans D, Stenova E, Lamy O. The trabecular bone score (TBS) complements DXA and the FRAX as a fracture risk assessment tool in routine clinical practice. Curr Osteoporos Rep. 2017;15(6):521\u201331.","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"646_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00223-016-0191-x","volume":"100","author":"GI Schacter","year":"2017","unstructured":"Schacter GI, Leslie WD. DXA-based measurements in diabetes: can they predict fracture risk? Calcif Tissue Int. 2017;100(2):150\u201364.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"646_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ecl.2016.09.005","volume":"46","author":"BC Silva","year":"2017","unstructured":"Silva BC, Leslie WD. Trabecular bone score: a new DXA-derived measurement for fracture risk assessment. Endocrinol Metab Clin N Am. 2017;46(1):153\u201380.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"646_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bone.2018.05.026","volume":"113","author":"P Martineau","year":"2018","unstructured":"Martineau P, et al. In which patients does lumbar spine trabecular bone score (TBS) have the largest effect? Bone. 2018;113:161\u20138 Intersting study evaluating the strenth of association between TBS and several fracture risk factors, including diabetes.","journal-title":"Bone"},{"issue":"9","key":"646_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222571","volume":"14","author":"M Yamamoto","year":"2019","unstructured":"Yamamoto M, Yamauchi M, Sugimoto T. Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus. PLoS One. 2019;14(9):e0222571.","journal-title":"PLoS One"},{"issue":"4","key":"646_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jocd.2016.04.001","volume":"19","author":"YJ Choi","year":"2016","unstructured":"Choi YJ, Ock SY, Chung YS. Trabecular bone score (TBS) and TBS-adjusted fracture risk assessment tool are potential supplementary tools for the discrimination of morphometric vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Densitom. 2016;19(4):507\u201314.","journal-title":"J Clin Densitom"},{"issue":"1","key":"646_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00198-015-3212-0","volume":"27","author":"VV Zhukouskaya","year":"2016","unstructured":"Zhukouskaya VV, et al. The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients. Osteoporos Int. 2016;27(1):49\u201356.","journal-title":"Osteoporos Int"},{"issue":"2","key":"646_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/GME.0000000000001185","volume":"26","author":"FP Chen","year":"2019","unstructured":"Chen FP, et al. Status of bone strength and factors associated with vertebral fracture in postmenopausal women with type 2 diabetes. Menopause. 2019;26(2):182\u20138.","journal-title":"Menopause"},{"key":"646_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2016.12.010","volume":"39","author":"SA Shapses","year":"2017","unstructured":"Shapses SA, Pop LC, Wang Y. Obesity is a concern for bone health with aging. Nutr Res. 2017;39:1\u201313.","journal-title":"Nutr Res"},{"issue":"4","key":"646_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00774-018-0960-x","volume":"37","author":"I Kanazawa","year":"2019","unstructured":"Kanazawa I, et al. Overweight and underweight are risk factors for vertebral fractures in patients with type 2 diabetes mellitus. J Bone Miner Metab. 2019;37(4):703\u201310.","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"646_CR33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00592-016-0880-y","volume":"53","author":"L Bianchi","year":"2016","unstructured":"Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: a major threat to patient's mobility and independence. Acta Diabetol. 2016;53(6):879\u201389.","journal-title":"Acta Diabetol"},{"issue":"4","key":"646_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2337\/dc18-1965","volume":"42","author":"G Li","year":"2019","unstructured":"Li G, et al. Frailty and risk of fractures in patients with type 2 diabetes. Diabetes Care. 2019;42(4):507\u201313.","journal-title":"Diabetes Care"},{"issue":"3","key":"646_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jcsm.12066","volume":"7","author":"P Szulc","year":"2016","unstructured":"Szulc P, Feyt C, Chapurlat R. High risk of fall, poor physical function, and low grip strength in men with fracture-the STRAMBO study. J Cachexia Sarcopenia Muscle. 2016;7(3):299\u2013311.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"646_CR36","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1507\/endocrj.EJ17-0011","volume":"64","author":"M Yokomoto-Umakoshi","year":"2017","unstructured":"Yokomoto-Umakoshi M, et al. Association between the risk of falls and osteoporotic fractures in patients with type 2 diabetes mellitus. Endocr J. 2017;64(7):727\u201334.","journal-title":"Endocr J"},{"key":"646_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bone.2019.01.009","volume":"121","author":"JT Schousboe","year":"2019","unstructured":"Schousboe JT, et al. Prevalent vertebral fracture on bone density lateral spine (VFA) images in routine clinical practice predict incident fractures. Bone. 2019;121:72\u20139.","journal-title":"Bone"},{"issue":"3","key":"646_CR38","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-16-0652","volume":"176","author":"K Hygum","year":"2017","unstructured":"Hygum K, et al. Mechanisms in endocrinology: diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol. 2017;176(3):R137\u201357.","journal-title":"Eur J Endocrinol"},{"key":"646_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bone.2015.07.027","volume":"82","author":"JN Farr","year":"2016","unstructured":"Farr JN, Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone. 2016;82:28\u201334.","journal-title":"Bone"},{"issue":"4","key":"646_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208\u201319.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"646_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","volume":"21","author":"M Saito","year":"2010","unstructured":"Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010;21(2):195\u2013214.","journal-title":"Osteoporos Int"},{"key":"646_CR42","doi-asserted-by":"crossref","unstructured":"Waqas K, et al. Skin autofluorescence, a noninvasive biomarker for advanced glycation end-products, is associated with prevalent vertebral and major osteoporotic fractures: the Rotterdam study. J Bone Miner Res. 2020.","DOI":"10.1002\/jbmr.4096"},{"issue":"4","key":"646_CR43","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/jbmr.3220","volume":"33","author":"L Oei","year":"2018","unstructured":"Oei L, et al. Osteoporotic vertebral fracture prevalence varies widely between qualitative and quantitative radiological assessment methods: the Rotterdam study. J Bone Miner Res. 2018;33(4):560\u20138.","journal-title":"J Bone Miner Res"},{"key":"646_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.biochi.2014.01.002","volume":"101","author":"X Dong","year":"2014","unstructured":"Dong X, et al. FFAs-ROS-ERK\/P38 pathway plays a key role in adipocyte lipotoxicity on osteoblasts in co-culture. Biochimie. 2014;101:123\u201331.","journal-title":"Biochimie"},{"key":"646_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejrad.2019.02.020","volume":"113","author":"L Zhu","year":"2019","unstructured":"Zhu L, et al. Marrow adiposity as an indicator for insulin resistance in postmenopausal women with newly diagnosed type 2 diabetes - an investigation by chemical shift-encoded water-fat MRI. Eur J Radiol. 2019;113:158\u201364.","journal-title":"Eur J Radiol"},{"issue":"2","key":"646_CR46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jbmr.3895","volume":"35","author":"GN Woods","year":"2020","unstructured":"Woods GN, et al. Greater bone marrow adiposity predicts bone loss in older women. J Bone Miner Res. 2020;35(2):326\u201332.","journal-title":"J Bone Miner Res"},{"key":"646_CR47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bone.2017.02.001","volume":"97","author":"Y Sheu","year":"2017","unstructured":"Sheu Y, et al. Vertebral bone marrow fat, bone mineral density and diabetes: the osteoporotic fractures in men (MrOS) study. Bone. 2017;97:299\u2013305.","journal-title":"Bone"},{"issue":"9","key":"646_CR48","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00198-017-4096-y","volume":"28","author":"D Martinez-Laguna","year":"2017","unstructured":"Martinez-Laguna D, et al. Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study. Osteoporos Int. 2017;28(9):2573\u201381.","journal-title":"Osteoporos Int"},{"issue":"1","key":"646_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-017-0324-x","volume":"102","author":"H Miyake","year":"2018","unstructured":"Miyake H, Kanazawa I, Sugimoto T. Association of bone mineral density, bone turnover markers, and vertebral fractures with all-cause mortality in type 2 diabetes mellitus. Calcif Tissue Int. 2018;102(1):1\u201313.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"646_CR50","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s00125-017-4283-6","volume":"60","author":"AV Schwartz","year":"2017","unstructured":"Schwartz AV. Diabetes, bone and glucose-lowering agents: clinical outcomes. Diabetologia. 2017;60(7):1170\u20139.","journal-title":"Diabetologia"},{"issue":"9","key":"646_CR51","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s00198-016-3595-6","volume":"27","author":"HJ Choi","year":"2016","unstructured":"Choi HJ, et al. Risk of fractures and diabetes medications: a nationwide cohort study. Osteoporos Int. 2016;27(9):2709\u201315.","journal-title":"Osteoporos Int"},{"issue":"3","key":"646_CR52","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/cen.12971","volume":"84","author":"M Notsu","year":"2016","unstructured":"Notsu M, et al. Serum dipeptidyl peptidase-4 is associated with multiple vertebral fractures in type 2 diabetes mellitus. Clin Endocrinol. 2016;84(3):332\u20137.","journal-title":"Clin Endocrinol"},{"key":"646_CR53","doi-asserted-by":"crossref","unstructured":"Lin F, et al. The effect of metformin on vertebral marrow fat in postmenopausal women with newly diagnosed type 2 diabetes mellitus. Menopause. 2019.","DOI":"10.1097\/GME.0000000000001473"},{"issue":"10","key":"646_CR54","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1002\/jcb.23206","volume":"112","author":"QG Mai","year":"2011","unstructured":"Mai QG, et al. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem. 2011;112(10):2902\u20139.","journal-title":"J Cell Biochem"},{"issue":"5","key":"646_CR55","first-page":"3957","volume":"17","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. Insulin use and fracture risk in patients with type 2 diabetes: a meta-analysis of 138,690 patients. Exp Ther Med. 2019;17(5):3957\u201364.","journal-title":"Exp Ther Med"},{"key":"646_CR56","doi-asserted-by":"crossref","unstructured":"Corrao G, et al. Is switching from oral antidiabetic therapy to insulin associated with an increased fracture risk? Clin Orthop Relat Res. 2019.","DOI":"10.1097\/CORR.0000000000001089"},{"key":"646_CR57","doi-asserted-by":"publisher","first-page":"115197","DOI":"10.1016\/j.bone.2019.115197","volume":"132","author":"K Hygum","year":"2020","unstructured":"Hygum K, et al. Bone resorption is unchanged by liraglutide in type 2 diabetes patients: a randomised controlled trial. Bone. 2020;132:115197.","journal-title":"Bone"},{"issue":"2","key":"646_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00223-016-0177-8","volume":"100","author":"AV Schwartz","year":"2017","unstructured":"Schwartz AV. Efficacy of osteoporosis therapies in diabetic patients. Calcif Tissue Int. 2017;100(2):165\u201373.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"646_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12020-018-1548-x","volume":"60","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, et al. Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review. Endocrine. 2018;60(3):373\u201383.","journal-title":"Endocrine"},{"key":"646_CR60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bone.2018.07.013","volume":"116","author":"BL Langdahl","year":"2018","unstructured":"Langdahl BL, et al. Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: integrated analysis of 4 prospective observational studies. Bone. 2018;116:58\u201366.","journal-title":"Bone"},{"key":"646_CR61","doi-asserted-by":"publisher","first-page":"115268","DOI":"10.1016\/j.bone.2020.115268","volume":"134","author":"S Ferrari","year":"2020","unstructured":"Ferrari S, et al. Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension. Bone. 2020;134:115268.","journal-title":"Bone"},{"key":"646_CR62","doi-asserted-by":"crossref","unstructured":"Malik AT, et al. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and Medicare advantage beneficiaries. Spine J. 2019.","DOI":"10.1016\/j.spinee.2019.05.043"},{"issue":"12","key":"646_CR63","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","volume":"29","author":"SL Ferrari","year":"2018","unstructured":"Ferrari SL, et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. 2018;29(12):2585\u201396.","journal-title":"Osteoporos Int"},{"issue":"1","key":"646_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","volume":"12","author":"J Compston","year":"2017","unstructured":"Compston J, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12(1):43.","journal-title":"Arch Osteoporos"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-020-00646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-020-00646-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-020-00646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T03:44:48Z","timestamp":1674877488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-020-00646-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1007\/s11914-020-00646-8","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"16 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"M.C.Z. reports receiving personal fees in the past honoraria for lectures or advice from Alexion, Amgen, Eli Lilly, Kyowa Kirin, Shire and UCB, unrelated to the current work. Outside the submitted work, L.O. reports a personal fee from Amgen for presentation at a conference, outside the submitted work. All other authors declared that there is no conflict of interest regarding the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported data coming from human studies performed by the authors have been previously published and complied with ethical standards including the Helsinki declaration and its amendments, institutional\/national research committee standards and guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}